- Home
- BMY vs BUD Comparison
BMY vs BUD Comparison
Compare BMY & BUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMY | BUD |
|---|---|---|
| Founded | 1887 | 1366 |
| Country | United States | Belgium |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.2B | 123.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BMY | BUD |
|---|---|---|
| Price | $55.48 | $68.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 1 |
| Target Price | $57.64 | ★ $88.00 |
| AVG Volume (30 Days) | ★ 14.3M | 1.7M |
| Earning Date | 02-05-2026 | 02-25-2026 |
| Dividend Yield | ★ 4.45% | 1.41% |
| EPS Growth | ★ N/A | N/A |
| EPS | 2.97 | ★ 3.00 |
| Revenue | $48,034,000,000.00 | ★ $58,605,000,000.00 |
| Revenue This Year | $0.28 | $0.67 |
| Revenue Next Year | N/A | $5.43 |
| P/E Ratio | ★ $19.06 | $22.92 |
| Revenue Growth | ★ 1.26 | N/A |
| 52 Week Low | $42.52 | $46.32 |
| 52 Week High | $63.33 | $72.13 |
Technical Indicators
Market Signals| Indicator | BMY | BUD |
|---|---|---|
| Relative Strength Index (RSI) | 57.97 | 70.07 |
| Support Level | $55.34 | $63.14 |
| Resistance Level | $57.04 | $69.15 |
| Average True Range (ATR) | 1.08 | 0.85 |
| MACD | -0.08 | 0.45 |
| Stochastic Oscillator | 68.17 | 88.25 |
Price Performance
Historical ComparisonAbout BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About BUD Anheuser-Busch Inbev SA Sponsored ADR (Belgium)
Anheuser-Busch InBev is the largest brewer in the world and one of the world's top five consumer product companies, as measured by EBITDA. The company's portfolio contains six of the top 10 beer brands by volume, according to Euromonitor, and we estimate it distributes 23 brands with retail sales over $1 billion. AB InBev was created by the 2008 merger of Belgium-based InBev and US-based Anheuser-Busch. The firm holds a 62% economic interest in Ambev, an 87% stake in Budweiser APAC, and in 2016 it acquired SABMiller.